Issue 45, 2019

Synthesis, structure and biological evaluation of mixed ligand oxidovanadium(iv) complexes incorporating 2-(arylazo)phenolates

Abstract

[VO(acac)2] was used as a metal precursor to synthesize a series of mixed ligand oxidovanadium(IV) complexes [VIVO(L1–4)(LNN)] (1–5) with tridentate ONO donor arylazo ligands (H2L1–4) (where H2L1 = 1-(2-hydroxyphenyl)diazenyl)naphthane-2-ol, H2L2 = 1-(2-hydroxy-4-methylphenyl)diazenyl)naphthane-2-ol, H2L3 = 1-(2-hydroxy-4-nitrophenyl)diazenyl)naphthane-2-ol and H2L4 = 1-(2-hydroxy-4-bromophenyl)diazenyl)naphthane-2-ol) along with an ancillary ligand (LNN), namely 2,2′-bipyridine (bipy) or 1,10-phenanthroline (phen) as a co-ligand. All complexes were characterized by spectroscopic, ESI-MS and X-ray crystallographic techniques, which show their distorted octahedral geometry. The molecular structure shows the presence of a vanadyl group in six-coordinated VIVN3O3 geometry. The species exhibit quasi-reversible one-electron transfer of Ec1/2 value between −1.29 and −1.37 V, while irreversible one-electron oxidation peaks lie in the range 0.37–0.67 V versus SCE in acetonitrile solution. All the complexes show DNA binding activity with CT-DNA having binding constant values in the range 7.1 × 103–2.03 × 104 M−1. The interaction of synthesized mixed ligand oxidovanadium(IV) species with bovine serum albumin (BSA) was also studied experimentally, which revealed moderate binding affinity. Further, the antiproliferative activity of 1–5 was examined against A549 (lung cancer) cancer cell lines by MTT assay. The cytotoxicity of the complexes is affected by the various functional groups attached to the arylazo derivative as well as the presence of two different co-ligands and 2 showed considerable antiproliferative activity compared to other chemotherapeutic drugs.

Graphical abstract: Synthesis, structure and biological evaluation of mixed ligand oxidovanadium(iv) complexes incorporating 2-(arylazo)phenolates

Supplementary files

Article information

Article type
Paper
Submitted
13 এপ্রিল 2019
Accepted
12 জুলাই 2019
First published
12 জুলাই 2019

New J. Chem., 2019,43, 17711-17725

Synthesis, structure and biological evaluation of mixed ligand oxidovanadium(IV) complexes incorporating 2-(arylazo)phenolates

S. Lima, A. Banerjee, M. Mohanty, G. Sahu, C. Kausar, S. K. Patra, E. Garribba, W. Kaminsky and R. Dinda, New J. Chem., 2019, 43, 17711 DOI: 10.1039/C9NJ01910C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements